Covered recipient · General Payments record
WODERYELESH T KASSA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2025
$4,475.14
- Reported across 219 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,852.27 | 98 |
| Education | $8.14 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $323.84 | 22 |
| Novo Nordisk AS | $291.16 | 19 |
| SANOFI-AVENTIS U.S. LLC | $224.99 | 8 |
| Abbott Laboratories | $197.05 | 12 |
| Bayer HealthCare Pharmaceuticals Inc. | $137.55 | 6 |
| Insulet Corporation | $107.83 | 5 |
| Ascendis Pharma Endocrinology Inc | $64.23 | 3 |
| MannKind Corporation | $57.57 | 2 |
| Esperion Therapeutics, Inc. | $52.55 | 3 |
| BETA BIONICS, INC. | $47.36 | 2 |
| ABBVIE INC. | $44.02 | 3 |
| Lilly USA, LLC | $38.19 | 2 |
| CeQur Corporation | $37.00 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $33.97 | 1 |
| Acella Pharmaceuticals, LLC | $27.93 | 2 |
| Medtronic, Inc. | $26.96 | 1 |
| Madrigal Pharmaceuticals | $24.65 | 1 |
| DEXCOM, INC. | $23.95 | 1 |
| Tandem Diabetes Care, Inc. | $22.74 | 1 |
| Rhythm Pharmaceuticals, Inc. | $22.42 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.12 | 1 |
| Amphastar Pharmaceuticals, Inc. | $18.21 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (99)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.